217196-94-6

Upstream product

• 217197-04-1 4-nitro-2-(2,5,5-trimethyl-1,3-dioxan-2-yl)-benzoic acid 
• 217197-05-2 C₁₄H₁₉NO₄ 

Downstream Products

• 217196-93-5 6-[3-(1-phenyl-cyclopropyl)-2-oxo-propionylamino]-4-methyl-2,3-benzoxazin-1-one 
• 217196-96-8 6-[3-(1-phenyl-cyclohexyl)-2-oxo-propionylamino]-4-methyl-2,3-benzoxazin-1-one 
• 1036031-31-8 6-[2-phenyl-2-oxoacetoylamino]-4-methyl-2,3-benzoxazin-1-one 
• 872835-09-1 3-(1-cyclohexyl-1,2,3,4-tetrahydro-1-naphthalenyl)-N-(4-methyl-1-oxo-1H-2,3-benzoxazin-6-yl)-2-oxopropanamide 
• 906342-14-1 N-(4-methyl-1-oxo-1H-benzo[d][1,2]oxazin-6-yl)-2-oxo-3-(1-phenyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-propionamide 
• 217197-00-7 6-[4-(5-fluoro-2-methoxyphenyl)-4-methyl-2-oxo-valeroylamino)-4-methyl-2,3-benzoxazin-1-one 
• 217197-08-5 6-(4-methyl-4-phenyl-2-oxo-valeroylamino)-4-methyl-2,3-benzoxazin-1-one 

Relevant academic research and scientific papers

Nonsteroidal gestagens

This invention describes the new, nonsteroidal gestagens of general formula I in which A, B, Ar, R1, R2and R3have the meanings that are indicated in more detail in the description. The new compounds show a very great affin

Nonsteroidal anti-inflammatory agents

This invention describes the use of the compounds of general formula I in which A, B, A, Ar, R1, R2and R3have the meaning that is indicated in more detail in the description, for the production of pharmaceutical agents with anti-inflammatory action. The compounds of general formula I show a clear dissociation between anti-inflammatory and metabolic action.